Akèy › Maladi atè koronè
Etid klinik pou Maladi atè koronè ap rekrite nan Etazini
66 etid pou Maladi atè koronè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY21 etid
- Boston, MA16 etid
- Dallas, TX15 etid
- Atlanta, GA15 etid
- Jacksonville, FL14 etid
- Minneapolis, MN13 etid
- Cleveland, OH13 etid
- Nashville, TN11 etid
- Columbus, OH10 etid
- Durham, NC9 etid
- Memphis, TN8 etid
- Houston, TX8 etid
- Indianapolis, IN8 etid
- Los Angeles, CA8 etid
- Philadelphia, PA8 etid
- Plano, TX8 etid
- Phoenix, AZ7 etid
- Portland, OR7 etid
- New Rochelle, NY7 etid
- Chicago, IL7 etid
- Cincinnati, OH7 etid
- The Bronx, NY7 etid
- Wichita, KS7 etid
- Buffalo, NY6 etid
- Birmingham, AL6 etid
- Pittsburgh, PA6 etid
- Little Rock, AR6 etid
- Baltimore, MD6 etid
- Aurora, CO6 etid
- Louisville, KY6 etid
- Huntsville, AL6 etid
- St. Louis, MO6 etid
- Raleigh, NC6 etid
- Queens, NY6 etid
- Tampa, FL6 etid
- Camden, NJ6 etid
- Oklahoma City, OK6 etid
- Milwaukee, WI5 etid
- Gainesville, FL5 etid
- San Diego, CA5 etid
Pa eta
- Alabama10 etid
- Arizona13 etid
- Arkansas6 etid
- Colorado13 etid
- Connecticut8 etid
- Distrik Columbia4 etid
- Florid24 etid
- Georgia18 etid
- Illinois10 etid
- Indiana14 etid
- Iowa6 etid
- Kalifòni23 etid
- Kansas9 etid
- Kentucky9 etid
- Lwizyàn4 etid
- Maryland8 etid
- Massachusetts18 etid
- Michigan13 etid
- Minnesota20 etid
- Mississippi5 etid
- Missouri10 etid
- Nebraska7 etid
- New Hampshire3 etid
- New Jersey15 etid
- New Mexico4 etid
- New York23 etid
- North Carolina19 etid
- Ohio22 etid
- Oklahoma7 etid
- Oregon8 etid
- Pennsylvania15 etid
- Rhode Island5 etid
- South Carolina8 etid
- Tennessee14 etid
- Texas23 etid
- Utah4 etid
- Virginia6 etid
- Washington6 etid
- West Virginia7 etid
- Wisconsin7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT07296744A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Sep 28, 2026 · NCT07286578Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565IVUS CHIP UPP Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06625801A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Product Surveillance Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276Tezspire Cardiac Events PASS
Ap rekriteEtid obsèvasyon
Laj 12 a 130 · Tout sèks · Mizajou Sep 18, 2026 · NCT06951867Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 20 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT06814587Factors Affect Outcomes in Cardiovascular Surgery
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT01932411Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 20 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT06047028Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07048808Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05111288REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06399705REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06399692A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT06164730Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07258290Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07691502Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT03504956Randomization of Single vs Multiple Arterial Grafts
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Aug 20, 2026 · NCT03217006Progress Bifurcation Global Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05100992Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 19, 2026 · NCT02061436Progress Complication
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05100940Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT07704918Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Gason · Mizajou Jul 27, 2026 · NCT05611307Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.